Product Code: ETC6102963 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Psoriasis Drugs Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Psoriasis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Psoriasis Drugs Market - Industry Life Cycle |
3.4 Angola Psoriasis Drugs Market - Porter's Five Forces |
3.5 Angola Psoriasis Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.6 Angola Psoriasis Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
4 Angola Psoriasis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about psoriasis and its treatment options among the population in Angola |
4.2.2 Rising healthcare expenditure and improving healthcare infrastructure in the country |
4.2.3 Growing demand for advanced and effective psoriasis drugs in the market |
4.2.4 Entry of new market players and introduction of innovative treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with psoriasis drugs leading to affordability issues for some patients |
4.3.2 Limited access to specialized healthcare facilities and dermatologists in remote areas of Angola |
4.3.3 Lack of reimbursement policies for psoriasis drugs under the healthcare system |
5 Angola Psoriasis Drugs Market Trends |
6 Angola Psoriasis Drugs Market, By Types |
6.1 Angola Psoriasis Drugs Market, By Therapeutic Class |
6.1.1 Overview and Analysis |
6.1.2 Angola Psoriasis Drugs Market Revenues & Volume, By Therapeutic Class, 2021- 2031F |
6.1.3 Angola Psoriasis Drugs Market Revenues & Volume, By Tumor Necrosis Factor Inhibitor, 2021- 2031F |
6.1.4 Angola Psoriasis Drugs Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2 Angola Psoriasis Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Angola Psoriasis Drugs Market Revenues & Volume, By Topicals, 2021- 2031F |
6.2.3 Angola Psoriasis Drugs Market Revenues & Volume, By Systemic, 2021- 2031F |
6.2.4 Angola Psoriasis Drugs Market Revenues & Volume, By Biologics, 2021- 2031F |
7 Angola Psoriasis Drugs Market Import-Export Trade Statistics |
7.1 Angola Psoriasis Drugs Market Export to Major Countries |
7.2 Angola Psoriasis Drugs Market Imports from Major Countries |
8 Angola Psoriasis Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed psoriasis treatment regimens |
8.2 Number of clinical trials conducted for new psoriasis drugs in Angola |
8.3 Rate of adoption of biologic therapies for psoriasis treatment |
8.4 Patient satisfaction levels with the effectiveness of psoriasis drugs |
8.5 Percentage of dermatologists in Angola trained in the latest psoriasis treatment protocols |
9 Angola Psoriasis Drugs Market - Opportunity Assessment |
9.1 Angola Psoriasis Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.2 Angola Psoriasis Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10 Angola Psoriasis Drugs Market - Competitive Landscape |
10.1 Angola Psoriasis Drugs Market Revenue Share, By Companies, 2024 |
10.2 Angola Psoriasis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |